Fortress Biotech, Inc. (FBIO)
Develops and sells medications treating skin conditions, acne, and rare diseases.
$3.39+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+87.3%
The outlook
FBIO trades at $3.39, positioned well above both its 50- and 200-day moving averages and roughly mid-range in its 52-week span. Analyst consensus targets average around $10.99, roughly 224% above the current price. The stock carries a trailing P/E of 1.0, suggesting minimal near-term earnings, though coverage appears limited on fundamentals.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range59% of the way from its 52-week low to high
Price targetAvg target +224% vs current price
Analyst price target
~12-month · 2 analysts$11.00average target+224.5% vs now
Now $3.39
Low $5.00High $17.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$112.6M
52-wk high
$4.53
52-wk low
$1.77
50-day avg
$2.98
200-day avg
$2.97
Trailing P/E
1.0